SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS


Creative Commons License

Armagan B., Kilic L., Yardimci G. K., Bilgin E., Farisogullari B., Bolek E. C., ...Daha Fazla

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.419-420, (Özet Bildiri)